Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine

Detalles Bibliográficos
Autores principales: Gillion, Valentine, Jadoul, Michel, Demoulin, Nathalie, Aydin, Selda, Devresse, Arnaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256676/
https://www.ncbi.nlm.nih.gov/pubmed/34237323
http://dx.doi.org/10.1016/j.kint.2021.06.033
_version_ 1783718145896218624
author Gillion, Valentine
Jadoul, Michel
Demoulin, Nathalie
Aydin, Selda
Devresse, Arnaud
author_facet Gillion, Valentine
Jadoul, Michel
Demoulin, Nathalie
Aydin, Selda
Devresse, Arnaud
author_sort Gillion, Valentine
collection PubMed
description
format Online
Article
Text
id pubmed-8256676
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Society of Nephrology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-82566762021-07-06 Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine Gillion, Valentine Jadoul, Michel Demoulin, Nathalie Aydin, Selda Devresse, Arnaud Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2021-09 2021-07-05 /pmc/articles/PMC8256676/ /pubmed/34237323 http://dx.doi.org/10.1016/j.kint.2021.06.033 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Gillion, Valentine
Jadoul, Michel
Demoulin, Nathalie
Aydin, Selda
Devresse, Arnaud
Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine
title Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine
title_full Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine
title_fullStr Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine
title_full_unstemmed Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine
title_short Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine
title_sort granulomatous vasculitis after the astrazeneca anti–sars-cov-2 vaccine
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256676/
https://www.ncbi.nlm.nih.gov/pubmed/34237323
http://dx.doi.org/10.1016/j.kint.2021.06.033
work_keys_str_mv AT gillionvalentine granulomatousvasculitisaftertheastrazenecaantisarscov2vaccine
AT jadoulmichel granulomatousvasculitisaftertheastrazenecaantisarscov2vaccine
AT demoulinnathalie granulomatousvasculitisaftertheastrazenecaantisarscov2vaccine
AT aydinselda granulomatousvasculitisaftertheastrazenecaantisarscov2vaccine
AT devressearnaud granulomatousvasculitisaftertheastrazenecaantisarscov2vaccine

Ejemplares similares